187 related articles for article (PubMed ID: 32959190)
1. Enrichment and detection of circulating tumor cells by immunomagnetic beads and flow cytometry.
Hu L; Chen X; Chen M; Fang J; Nie J; Dai H
Biotechnol Lett; 2021 Jan; 43(1):25-34. PubMed ID: 32959190
[TBL] [Abstract][Full Text] [Related]
2. Enumeration of Circulating Tumor Cells and Disseminated Tumor Cells in Blood and Bone Marrow by Immunomagnetic Enrichment and Flow Cytometry (IE/FC).
Magbanua MJM; Solanki TI; Ordonez AD; Hsiao F; Park JW
Methods Mol Biol; 2017; 1634():203-210. PubMed ID: 28819853
[TBL] [Abstract][Full Text] [Related]
3. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
[TBL] [Abstract][Full Text] [Related]
5. Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling.
Magbanua MJ; Park JW
Methods; 2013 Dec; 64(2):114-8. PubMed ID: 23896286
[TBL] [Abstract][Full Text] [Related]
6. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma.
Wang N; Tesfaluul N; Li J; Gao X; Liu S; Yue B
Ann Hematol; 2019 Dec; 98(12):2769-2780. PubMed ID: 31748925
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Different Surgical Approaches on the Perioperative Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer.
Huang HB; Ge MJ
Thorac Cardiovasc Surg; 2016 Sep; 64(6):515-9. PubMed ID: 26030121
[TBL] [Abstract][Full Text] [Related]
9. Clinical test on circulating tumor cells in peripheral blood of lung cancer patients, based on novel immunomagnetic beads.
Wang B; Wang B; Zhang D; Guo H; Zhang L; Zhou W
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):892-7. PubMed ID: 25682839
[TBL] [Abstract][Full Text] [Related]
10. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers.
Guo J; Xiao B; Zhang X; Jin Z; Chen J; Qin L; Mao X; Shen G; Chen H; Liu Z
J Mol Med (Berl); 2004 Nov; 82(11):768-74. PubMed ID: 15490093
[TBL] [Abstract][Full Text] [Related]
11. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
[TBL] [Abstract][Full Text] [Related]
12. [Detection of circulating tumor cells in patients with hepatocellular carcinoma].
Mu H; Lin K; Zhao H; Li C; Sun Y; Cai J; Zhao X
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):276-81. PubMed ID: 24989914
[TBL] [Abstract][Full Text] [Related]
13. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
[TBL] [Abstract][Full Text] [Related]
14. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.
Brooimans RA; de Leeuw N; Bontenbal M; Gratama JW
J Biol Regul Homeost Agents; 2005; 19(1-2):84-91. PubMed ID: 16178280
[TBL] [Abstract][Full Text] [Related]
15. Immunomagnetic antibody plus aptamer pseudo-DNA nanocatenane followed by rolling circle amplication for highly-sensitive CTC detection.
Wang J; Dong HY; Zhou Y; Han LY; Zhang T; Lin M; Wang C; Xu H; Wu ZS; Jia L
Biosens Bioelectron; 2018 Dec; 122():239-246. PubMed ID: 30267982
[TBL] [Abstract][Full Text] [Related]
16. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry.
Takao M; Takeda K
Cytometry A; 2011 Feb; 79(2):107-17. PubMed ID: 21246706
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte-Repelling Biomimetic Immunomagnetic Nanoplatform for High-Performance Circulating Tumor Cells Isolation.
Zhou X; Luo B; Kang K; Zhang Y; Jiang P; Lan F; Yi Q; Wu Y
Small; 2019 Apr; 15(17):e1900558. PubMed ID: 30932344
[TBL] [Abstract][Full Text] [Related]
18. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
[TBL] [Abstract][Full Text] [Related]
19. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
20. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers.
Hristozova T; Konschak R; Budach V; Tinhofer I
Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
